Marker testowy guza YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 is an advanced diagnostic tool designed for precision in early cancer detection. By utilizing chemiluminescence immunoassay analyzers, this test kit can detect 18 different tumor markers, providing crucial data for diagnosing and monitoring various malignant tumors. With models ranging from YRA385 to YRA391, each kit is tailored to test specific parameters such as AFP, CEA, and t-PSA among others. The flexibility in model options ensures suitability for a range of diagnostic requirements, making it an invaluable asset in clinical settings.

Market Price

In the competitive landscape of diagnostic tools, the Tumor Test Marker YRA385 // YRA391 offers a balance of affordability and cutting-edge technology. Prices for these types of tumor marker test kits typically range from $200 to $500 per box, depending on the model and the number of tests included. When considering the long-term benefits of early cancer detection, this investment is both practical and economically sound.

Frequently Asked Questions

What are the main tumor markers detected by this kit? The kit detects markers such as AFP, CEA, CA125, and others totaling 18 different parameters.

What technology does the kit use? It operates using the chemiluminescence immunoassay (CLIA) technology, which is known for its high sensitivity and specificity.

Advantages and Disadvantages

The primary advantage of the Tumor Test Marker is its comprehensive detection capability across multiple tumor markers, enhancing the potential for early cancer diagnosis. However, as with any diagnostic tool, false positives or negatives can occur, which may necessitate further testing. Additionally, while initial costs may be high, the long-term benefits and potential for early intervention outweigh these concerns.

Use in the Field

In clinical practice, the Tumor Test Marker YRA385 // YRA391 is used to identify elevated levels of tumor markers in blood samples. Healthcare professionals analyze these results to confirm or rule out the presence of malignant tumors, enabling timely and targeted treatment strategies. This makes them an essential tool in hospitals and diagnostic labs.

Recommendations

For optimal performance, it is recommended to store the kit at temperatures between 2-8°C. Regular calibration checks using the 2/6 Points calibration system are advised to maintain accuracy. Healthcare providers are encouraged to integrate these kits into routine diagnostic protocols to enhance patient outcomes.

Features

• Detects 18 tumor markers
• Compatible with CLIA technology
• Comprehensive model range: YRA385 to YRA391
• Packaged for various testing capacities: 50T/BOX, 100T/BOX, 24T/BOX
• Includes essential certifications: CE, ISO13485, FSC

Technical Specifications